← Evidence map

ArticleOncogene2011

Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours.

N Rajan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

37 papers cite it

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 21552290